Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Abdominal Radiology (New York)|July 6, 2018
Imaging and staging of neuroendocrine cervical cancerSherif Elsherif, Erika G L C Odisio, Silvana Faria, et al.
Gynecologic Oncology|April 9, 2022
Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR studyGloria Salvo, Anuja Jhingran, Preetha Ramalingam, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 12, 2021
Malignant Peritoneal Mesothelioma Associated With Endometriosis: A Clinicopathologic Study of 15 CasesAnais Malpica, Elizabeth D Euscher, Mario L Marques-Piubelli, et al.
Neoplasia (New York, N.Y.)|January 30, 2009
Aberrant promoter methylation of SPARC in ovarian cancerMatthew J Socha, Neveen Said, Yanshan Dai, et al.
Annals of Diagnostic Pathology|April 29, 2025
Mucinous neoplasms associated with mature cystic teratomas: A clinicopathologic study of 50 cases: Are we ready for nomenclature change?Preetha Ramalingam, Mario L Marques-Piubelli, Isabel Alvarado-Cabrero, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2023
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR studyMichael Frumovitz, Ajaykumar C Morani, Aatiqah Aziz, et al.
Annals of Diagnostic Pathology|January 18, 2011
Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissueMichelle D Reid-Nicholson, Nisrin Motiwala, Scott C Drury, et al.
The American Journal of Surgical Pathology|June 17, 2022
Localized Malignant Peritoneal Mesothelioma (LMPeM) in Women: A Clinicopathologic Study of 18 CasesAnais Malpica, Elizabeth D Euscher, Mario L Marques-Piubelli, et al.
The American Journal of Surgical Pathology|October 26, 2019
A 3-Tier Chemotherapy Response Score for Ovarian/Fallopian Tube/Peritoneal High-grade Serous Carcinoma: Is it Clinically Relevant?Barrett C Lawson, Elizabeth D Euscher, Roland L Bassett, et al.
Frontiers in Oncology|September 2, 2025
TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomasYingao Zhang, Savannah Barkdull, Panayiotis D Kontoyiannis, et al.
Pageof 9